Drug Profile
Research programme: serotonin receptor modulators - AnaMar AB
Alternative Names: AIDA; MITRALatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator AnaMar AB
- Class Small molecules
- Mechanism of Action Serotonin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cardiovascular disorders; Fibrosis; Inflammation; Inflammatory pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cardiovascular-disorders in Sweden (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Fibrosis in Sweden (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in Sweden (PO)